Merck & Co., Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Merck & Co., Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Merck & Co., Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $929M, a 6.78% increase year-over-year.
  • Merck & Co., Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $1.56B, a 44.9% decline year-over-year.
  • Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2023 was $1.51B, a 21.2% decline from 2022.
  • Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2022 was $1.92B, a 26.1% increase from 2021.
  • Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2021 was $1.52B, a 13.5% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.56B $929M +$59M +6.78% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $1.5B $545M -$92M -14.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $1.59B $903M +$78M +9.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $1.51B -$820M -$1.32B -265% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $2.83B $870M +$540M +164% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $2.29B $637M +$99M +18.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $2.19B $825M +$271M +48.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $1.92B $496M +$411M +484% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $1.51B $330M -$365M -52.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $1.87B $538M +$35M +6.96% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.84B $554M +$316M +133% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $1.52B $85M +$140M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $1.38B $695M +$315M +82.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.07B $503M +$107M +27% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $959M $238M -$381M -61.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.34B -$55M -$360M -118% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $1.7B $380M -$60M -13.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $1.76B $396M -$219M -35.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $1.98B $619M +$414M +202% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $1.57B $305M -$522M -63.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $2.09B $440M -$267M -37.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.35B $615M +$245M +66.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $2.11B $205M -$399M -66.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2.51B $827M -$2.09B -71.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $4.6B $707M +$456M +182% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $4.14B $370M -$118M -24.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $4.26B $604M +$157M +35.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $4.1B $2.92B +$3.69B Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $416M $251M -$448M -64.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $864M $488M +$193M +65.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $671M $447M -$47M -9.51% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $718M -$770M -$604M -364% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $1.32B $699M +$133M +23.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $1.19B $295M +$176M +148% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $1.01B $494M +$71M +16.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $942M -$166M -$4.65B -104% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $5.59B $566M -$82M -12.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $5.67B $119M +$261M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $5.41B $423M +$63M +17.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $5.35B $4.48B +$4.07B +996% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $1.28B $648M +$273M +72.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $1B -$142M -$452M -146% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $1.45B $360M +$426M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $1.03B $409M +$24M +6.23% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $1B $375M -$80M -17.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $1.08B $310M -$550M -64% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $1.63B -$66M -$806M -109% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $2.44B $385M +$347M +913% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $2.09B $455M -$173M -27.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $2.27B $860M +$1.24B Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $1.02B $740M +$82M +12.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 $942M $38M +$240M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 $702M $628M +$502M +398% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $200M -$382M -$843M -183% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $1.04B $658M +$372M +130% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $671M -$202M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $126M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $461M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $286M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.